Graphic Online
BY: Regional Desk Report
705
An international implementation committee has been established for the “Operation Clean Communities” launched by the New Juaben Traditional Council.
The campaign forms part of the traditional council’s community development efforts within the existing root-based model.
The committee is made up of representatives from the International Water and Sanitation Centre (IRC), Emory University in Atlanta, USA; the New Juaben Traditional Council and the root-based institutional members.
Meeting
At its maiden meeting last Tuesday, under the chairmanship of the Omanhene of New Juaben, Daasebre Prof. (Emeritus) Oti Boateng, the committee decided to implement the operation clean communities in three phases, namely the pre-intervention phase, the intervention phase and the post-intervention phase.
Fermenta Biotech brings multiple routes to synthesise Molnupiravir for COVID-19 treatment
Fermenta Biotech brings multiple routes to synthesise Molnupiravir for COVID-19 treatment
16 April 2021 | News Pioneers the development of its patented enzymatic route of synthesis for Molunpiravir an investigational ‘orally active’ therapeutic alternative for COVID-19
Image credit- shutterstock.com
Fermenta Biotech Limited (FBL) has announced that it has successfully developed and filed patent application(s) for novel biocatalytic technology of manufacturing Molnupiravir.
The patented enzymatic route of synthesis possesses the technological advantage of being efficient and environment-friendly, with higher yields and lower solvent use as compared to existing reported manufacturing processes. Biocatalysis is defined as the use of natural substances that include enzymes from biological sources or whole cells to speed up chemical reactions.
HIN
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a network of research sites to study the natural history, transmission and pathogenesis of influenza and provide an international research infrastructure to address influenza outbreaks. The program, called the Centers of Excellence for Influenza Research and Response (CEIRR), is expected to be supported for seven years by NIAID contracts to five institutions. Funding for the first year of the contracts will total approximately $24 million. CEIRR will replace the Centers of Excellence for Influenza Research and Surveillance (CEIRS) program, which was supported by contracts that concluded on March 31, 2021.
Editorial Roundup: Alabama
Recent editorials from Alabama newspapers:
The Decatur Daily on the COVID-19 vaccine and the variant viruses:
The race against the new coronavirus is a race against time. The longer it takes to vaccinate people and the longer it takes for populations to reach herd immunity, the more time the virus that causes COVID-19 has to mutate.
The COVID variants are deadlier and more readily spread than the original version at the start of the pandemic a year ago. These variants are the main reason for the deadly surge now sweeping much of Europe (but not the United Kingdom) and South America.
E-Mail
IMAGE: Colorized transmission electron micrograph of swine influenza virus particles (green) attached to and budding from the surface of a cell (purple). view more
Credit: NIAID
WHAT:
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a network of research sites to study the natural history, transmission and pathogenesis of influenza and provide an international research infrastructure to address influenza outbreaks. The program, called the Centers of Excellence for Influenza Research and Response (CEIRR), is expected to be supported for seven years by NIAID contracts to five institutions. Funding for the first year of the contracts will total approximately $24 million. CEIRR will replace the Centers of Excellence for Influenza Research and Surveillance (CEIRS) program, which was supported by contracts that concluded on March 31, 2021.